Skip to main content
. 2014 Sep 24;9:213. doi: 10.1186/1748-717X-9-213

Table 3.

Clinical outcomes

2-year rates 5-year rates
Overall survival 65.7% 50.8%
Bladder cancer specific survival 77.3% 67.3%
Survival with intact bladder* 64.2% 49.0%
Local-regional control 69.8% 61.7%
Distant-metastasis-free survival 73.5% 67.1%
Progression-free survival 51.9% 39.9%

*Only one patient with local failure received radical cystectomy as salvage treatment.